NAAA
COLL icon

New Age Alpha Advisors’s Collegium Pharmaceutical COLL Stock Holding History

New Age Alpha Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,383
Closed -$39.6K – 935
2024
Q4 		$39.6K Buy
+1,383
New +$45.8K ﹤0.01% 808

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New Age Alpha Advisors's COLL Position: Q1 2025 in Review

New Age Alpha Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 1,383 shares — an estimated $39.6K sold.

New Age Alpha Advisors first reported a position in COLL in Q4 2024 and held it in 1 quarter. The position peaked at $39.6K in Q4 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • New Age Alpha Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • New Age Alpha Advisors sold 1,383 Collegium Pharmaceutical shares in Q1 2025, an estimated $39.6K.
  • New Age Alpha Advisors first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 1 quarter.
  • New Age Alpha Advisors's Collegium Pharmaceutical position peaked at $39.6K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on New Age Alpha Advisors's 13F filing for Q1 2025, filed 9 May 2025.